As both ERK1/2 and EGFR activities are hallmarks of cell proliferation, an intriguing theory is that these interactions contribute to the association of PM-localized GPR30 with high Ki67 and poor BC outcome observed in this CBC material. The gene discussed is EGFR; the disease is breast cancer.